Beijing, China

Ke Zeng

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 82(Granted Patents)


Location History:

  • Taizhou, CN (2017)
  • Beijing, CN (2011 - 2020)
  • Jiangsu, CN (2016 - 2021)

Company Filing History:


Years Active: 2011-2025

where 'Filed Patents' based on already Granted Patents

27 patents (USPTO):

Title: Innovations in Oncology: The Contributions of Ke Zeng

Introduction: Ke Zeng, based in Beijing, China, is a prominent inventor with a remarkable portfolio comprising 26 patents. His innovative work primarily focuses on biotechnology, particularly in the field of cancer research. Zeng's inventions aim to develop effective diagnostic tools and therapeutic applications, significantly advancing the fight against cancer.

Latest Patents: Among Zeng's latest patents is the groundbreaking invention titled "K-RAS gene expression-suppressing siRNA, precursor of same, and applications thereof." This invention comprises an siRNA that inhibits K-RAS gene expression. The K-RAS siRNA has demonstrated efficacy in in vivo experiments, showing a suppressive effect on tumors that highly express the K-RAS gene. Zeng's work provides crucial insights into gene regulation mechanisms that could lead to innovative treatments for cancer.

Another significant patent is centered around "Serum or plasma microRNA as biomarkers for non-small cell lung cancer." This invention identifies stable microRNA markers detectable in human serum or plasma, offering a novel diagnostic tool for non-small cell lung cancer. The approaches Zeng developed enable high sensitivity and low-cost specimen collection, addressing challenges associated with specificity in previous markers and enhancing overall disease detection rates.

Career Highlights: Ke Zeng has made substantial contributions through his associations with well-known biotechnology companies, including Jiangsu Micromedmark Biotech Co., Ltd. and Micromedmark Biotech Co., Ltd. His work in these companies has facilitated the application of his patented technologies in real-world settings, driving advancements in cancer diagnostics and treatment.

Collaborations: Throughout his career, Zeng has collaborated with fellow professionals in the field, including Chenyu Zhang and Junfeng Zhang. These partnerships have allowed for the cross-pollination of ideas, further enriching the research and development processes behind Zeng's innovative projects.

Conclusion: Ke Zeng's remarkable body of work reflects his commitment to advancing cancer research and diagnostics. With a growing list of patents and valuable collaborations, Zeng continues to play a vital role in shaping the future of oncology through his innovative solutions and dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…